Skip to main content
. 2017 Sep 6;7:10633. doi: 10.1038/s41598-017-10410-1

Figure 6.

Figure 6

Inhibition of CBR1 in a murine model of diet-induced obesity results in increased GR activation and metabolic dysfunction. (A) Hepatic 20β-DHB levels were significantly lower in quercetin treated mice, (B) 20β-DHFB levels were not altered in subcutaneous adipose tissue, (C) plasma 20β-DHB levels were not altered by quercetin treatment (D) quercetin treatment resulted in increased peak plasma corticosterone levels. (E) Bodyweight was not different between mice in the vehicle treated group and mice treated with quercetin. (F,G) Quercetin-treated mice were significantly more insulin resistant and had higher fasted plasma insulin concentrations. (H) mRNA transcript levels of hepatic Per1 were increased in quercetin treated mice, (I) Adipose mRNA expression of Per1, Adiponectin (Adipq) and lipoprotein lipase (Lpl) were not altered by quercetin treatment. Data are mean ± SEM, n = 12/group, *P < 0.05.